299 related articles for article (PubMed ID: 31311580)
1. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
[TBL] [Abstract][Full Text] [Related]
2. The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells.
Berardinelli F; Siteni S; Tanzarella C; Stevens MF; Sgura A; Antoccia A
DNA Repair (Amst); 2015 Jan; 25():104-15. PubMed ID: 25467559
[TBL] [Abstract][Full Text] [Related]
3. The G-quadruplex-stabilizing ligand RHPS4 enhances sensitivity of U251MG glioblastoma cells to clinical carbon ion beams.
Berardinelli F; Sgura A; Facoetti A; Leone S; Vischioni B; Ciocca M; Antoccia A
FEBS J; 2018 Apr; 285(7):1226-1236. PubMed ID: 29484821
[TBL] [Abstract][Full Text] [Related]
4. Naphthalene diimide-derivatives G-quadruplex ligands induce cell proliferation inhibition, mild telomeric dysfunction and cell cycle perturbation in U251MG glioma cells.
Muoio D; Berardinelli F; Leone S; Coluzzi E; di Masi A; Doria F; Freccero M; Sgura A; Folini M; Antoccia A
FEBS J; 2018 Oct; 285(20):3769-3785. PubMed ID: 30095224
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study.
Palma A; Grande S; Luciani AM; Ricci-Vitiani L; Buccarelli M; Pallini R; Triveri A; Pirota V; Doria F; D'Alessandris QG; Berardinelli F; Antoccia A; Rosi A
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884511
[TBL] [Abstract][Full Text] [Related]
6. Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.
Tachon G; Cortes U; Guichet PO; Rivet P; Balbous A; Masliantsev K; Berger A; Boissonnade O; Wager M; Karayan-Tapon L
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282933
[TBL] [Abstract][Full Text] [Related]
7. Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells.
Ahmed SU; Carruthers R; Gilmour L; Yildirim S; Watts C; Chalmers AJ
Cancer Res; 2015 Oct; 75(20):4416-28. PubMed ID: 26282173
[TBL] [Abstract][Full Text] [Related]
8. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
[TBL] [Abstract][Full Text] [Related]
9. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
10. G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.
Hasegawa D; Okabe S; Okamoto K; Nakano I; Shin-ya K; Seimiya H
Biochem Biophys Res Commun; 2016 Feb; 471(1):75-81. PubMed ID: 26845351
[TBL] [Abstract][Full Text] [Related]
11. Mangiferin induces radiosensitization in glioblastoma cells by inhibiting nonhomologous end joining.
Mu F; Liu T; Zheng H; Xie X; Lei T; He X; Du S; Tong R; Wang Y
Oncol Rep; 2018 Dec; 40(6):3663-3673. PubMed ID: 30272350
[TBL] [Abstract][Full Text] [Related]
12. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
[TBL] [Abstract][Full Text] [Related]
13. RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.
King HO; Brend T; Payne HL; Wright A; Ward TA; Patel K; Egnuni T; Stead LF; Patel A; Wurdak H; Short SC
Stem Cell Reports; 2017 Jan; 8(1):125-139. PubMed ID: 28076755
[TBL] [Abstract][Full Text] [Related]
14. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
[TBL] [Abstract][Full Text] [Related]
15. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
[TBL] [Abstract][Full Text] [Related]
16. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.
Kahn J; Hayman TJ; Jamal M; Rath BH; Kramp T; Camphausen K; Tofilon PJ
Neuro Oncol; 2014 Jan; 16(1):29-37. PubMed ID: 24311635
[TBL] [Abstract][Full Text] [Related]
17. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
[TBL] [Abstract][Full Text] [Related]
18. H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.
Zhang W; Duan R; Zhang J; Cheung WKC; Gao X; Zhang R; Zhang Q; Wei M; Wang G; Zhang Q; Mei PJ; Chen HL; Kung H; Lin MC; Shen Z; Zheng J; Zhang L; Yao H
Br J Cancer; 2018 Feb; 118(4):522-533. PubMed ID: 29348487
[TBL] [Abstract][Full Text] [Related]
19. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]